Research programme: varicella vaccine - Chongqing Zhifei Biological Products
Latest Information Update: 24 Oct 2021
At a glance
- Originator Chongqing Zhifei Biological Products
- Class Varicella vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Varicella zoster virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Varicella-zoster-virus-infections in China (Parenteral, Injection)
- 30 Oct 2012 Preclinical trials in Varicella zoster virus infections in China (Parenteral)